[
    [
        {
            "time": "2020-08-20",
            "original_text": "格隆汇港股聚焦(8.20)︱阿里2021财年Q1营收1537.5亿元；美团点评明日发布中期业绩",
            "features": {
                "keywords": [
                    "阿里",
                    "2021财年Q1",
                    "营收",
                    "美团点评",
                    "中期业绩"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "互联网"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(8.20)︱阿里2021财年Q1营收1537.5亿元；美团点评明日发布中期业绩",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-08-21",
            "original_text": "多家公司公告第三批全国药品集中采购拟中标信息",
            "features": {
                "keywords": [
                    "药品集采",
                    "中标",
                    "华海",
                    "海正",
                    "恒瑞",
                    "豪森"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "多家公司公告第三批全国药品集中采购拟中标信息",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-20",
            "original_text": "上海医药：6个品种拟中标第三批全国药品集中采购",
            "features": {
                "keywords": [
                    "上海医药",
                    "药品集采",
                    "中标"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药：6个品种拟中标第三批全国药品集中采购",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-08-20",
            "original_text": "外资与本土药企“牵手”，能否成为带量采购的新出路？",
            "features": {
                "keywords": [
                    "外资",
                    "本土药企",
                    "带量采购"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "外资与本土药企“牵手”，能否成为带量采购的新出路？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-08-20",
            "original_text": "国投瑞银创新医疗混合基金最新净值跌幅达2.29%",
            "features": {
                "keywords": [
                    "国投瑞银",
                    "创新医疗",
                    "净值",
                    "跌幅"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "基金"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国投瑞银创新医疗混合基金最新净值跌幅达2.29%",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]